Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Original Article

J App Pharm Sci. 2021; 11(7): 117-126

Evaluating the effect of dopamine-geldanamycin hybrids on anticancer activity

Thongchai Taechowisan, Tipparat Samsawat, Chanjira Jaramornburapong, Weerachai Phutdhawong, Waya S. Phutdhawong.

Geldanamycin (GDM) is an antibiotic isolated from Streptomyces zerumbet W14 that specifically targets and deactivates heat shock protein 90 (Hsp90), directed to the functional protein deficiency. The utilization management of GDM has been limited by its poor water solubility and hepatotoxicity. Five new dopamine-geldanamycin hybrids (DGH), compounds 2 to 6, were synthesized from GDM (1). Solubility, cytotoxicity, anticancer activity, molecular docking, and ADMET analyses were carried out. The solubility of DGH in water was 0.3865.464 mM, higher than that of compound 1. These compounds showed weak cytotoxic activity against Vero cells and LLC-MK2, with IC50 values in the range of 104.52496.31 g/ml. Compounds 2, 3, and 6 were also active against MDA-MB231 cells with IC50 values of 41.88, 52.12, and 70.93 g/ml, respectively. They interacted positively with Hsp90, showing binding free energy (∆G) of −97.03 to −101.06 kcal/mol, which indicated lower Hsp90 affinity compared with that of GDM (−133.06 kcal/mol) and 17-dimethylamino ethylamino-17-demethoxygeldanamycin (−136.55 kcal/mol), despite being partly bound in the active site (compounds 2, 3, and 6) or outside the active site (compound 4). Since compound 4 bound outside the active side and compound 5 did not bind to any part of Hsp90, they were not active on cytotoxicity against both normal cells and cancer cells. The predicted results showed that the ADMET parameters of DGH were similar to those of GDM. Furthermore, the experimental results are associated with a theoretical basis by molecular docking and ADMET analysis. The study findings revealed, through molecular docking and ADMET analysis, that the development of DGH improved the pharmacokinetic profiles of solubility, cytotoxicity, and anticancer activities. We, therefore, recommend DGH as a potential alternative treatment agent for some cancers.

Key words: ADMET analysis, anticancer activity, cytotoxicity activity, dopamine-geldanamycin hybrids, heat shock protein 90, molecular docking, water solubility.

Similar Articles

Multiclass cyanotoxin analysis in reservoir waters: Tandem solid-phase extraction followed by zwitterionic hydrophilic interaction liquid chromatography-mass spectrometry.
Aparicio-Muriana MM, Carmona-Molero R, Lara FJ, García-Campaña AM, Del Olmo-Iruela M
Talanta. 2022; 237(): 122929

SARS-CoV-2 detection with aptamer-functionalized gold nanoparticles.
Aithal S, Mishriki S, Gupta R, Sahu RP, Botos G, Tanvir S, Hanson RW, Puri IK
Talanta. 2022; 236(): 122841

Analysis of Commitment Point Attainment in Algae Dividing by Multiple Fission.
Kselíková V, Zachleder V, Bišová K
Methods in molecular biology (Clifton, N.J.). 2022; 2382(): 89-101

MTA1, a metastasis‑associated protein, in endothelial cells is an essential molecule for angiogenesis.
Ishikawa M, Osaki M, Uno N, Ohira T, Kugoh H, Okada F
Molecular medicine reports. 2022; 25(1):

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Goulding SR, Anantha J, Collins LM, Sullivan AM, O'Keeffe GW
Neural regeneration research. 2022; 17(1): 38-44

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.

ScopeMed Web Sites